Infection Control

Infection Control

Global Infection Control Market to Reach $65.8 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Infection Control estimated at US$40.3 Billion in the year 2020, is projected to reach a revised size of US$65.8 Billion by 2027, growing at a CAGR of 7.2% over the analysis period 2020-2027. Protective Barriers, one of the segments analyzed in the report, is projected to record a 9.2% CAGR and reach US$26.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Sterilization Products & Services segment is readjusted to a revised 7.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $11.2 Billion, While China is Forecast to Grow at 8.8% CAGR

The Infection Control market in the U.S. is estimated at US$11.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.8 Billion by the year 2027 trailing a CAGR of 8.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 7.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.2 Billion by the year 2027.

Cleaning & Disinfection Products Segment to Record 5.7% CAGR

In the global Cleaning & Disinfection Products segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.9 Billion in the year 2020 will reach a projected size of US$8.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 6.1% CAGR through the analysis period.

Select Competitors (Total 145 Featured) -

  • 3M Company
  • Advanced Sterilization Products
  • Belimed AG
  • Cantel Medical Corporation
  • Cisa Production S.r.l.
  • Ecolab, Inc.
  • Getinge AB (Sweden)
  • Honeywell International, Inc.
  • Kimberly-Clark Corporation
  • Matachana Group
  • MELAG Medizintechnik GmbH & Co. KG
  • Metrex Research Corporation
  • Miele & Cie. KG
  • MMM Group
  • Nordion, Inc.
  • Pal International
  • Reckitt Benckiser Group Plc
  • Sakura Global Holding Company Ltd.
  • SHIMADZU CORPORATION
  • Sotera Health Co.
  • STERIS Corporation
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
The Never-Ending “Race” Between the Virus & Vaccines Continues. Amidst this Chaotic Battle, Where is the World Economy Heading Now & Beyond?
Omicron Spreads Panic Worldwide; Omicron Variant Brings Back Memories & Fears of the Worst Part of the 2020 Pandemic
South Africa: Omicron’s Origin Location
Short-term Impact of Omicron on Travel
Financial Impact
Scientists Seek to Gather More Information on Omicron
Pharma Firms Aim to Improve Existing Vaccines to Counter Omicron
Omicron: Impact on Travel Industry
Steps taken by the Countries to Prevent Transmission of Omicron Variant
With IMF Making an Upward Revision of Global GDP for 2021, Companies Are Bullish About an Economic Comeback Despite a Continuing Pandemic
A Strong Yet Exceedingly Patchy & Uncertain Recovery Shaped by New Variants Comes Into Play: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
Impact of COVID-19 on Infection Control Market
Infection Control – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Global Market Analysis and Prospects
Product and End-use Segments
Regional Market Analysis
Market Growth Restraining Factors
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Sterilization Equipment Market Witnesses Rapid Growth
Major Players in the Global Sterilization Equipment Market
Low-Temperature Sterilization Gains Ground
Leading Players in the Low-Temperature Sterilization Market
Emergence of Outsourcing Trend Bodes Well for Sterilization Services
E-beam Sterilization of Medical Devices Registers Rapid Growth
Endoscope Contamination – A Major Health Hazard Driving the Demand for Sterilization Equipment
Increasing Need to Reduce Hospital-Acquired Infections Propel Market Demand
Leading Nosocomial Infections in the US: Percentage Breakdown of Healthcare Cost by Infection Type
Central Line-Associated Bloodstream Infection (CLABSI) SIR in the US Hospitals: 2010 to 2016
Catheter-associated Urinary Tract Infection (CAUTI) SIR in the US Hospitals: 2010 to 2016
Surgical Site Infections SIR of Abdominal Hysterectomy in the US Hospitals: 2010-2021
Government Support to Ensure Infection Control in Clinical Settings to Boost Demand for Infection Control Products
Increasing Prevalence of Chronic Disorders, Rise in Surgical Procedures and the Need to Prevent Transmission of Infections Fuels Market Growth
No. of Surgical Procedures in Aging Population in the US (2016, 2018 & 2022)
Aging Population – A Key Growth Driver
Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Rising Demand for Medical Devices Augurs Well for the Market
COVID-19 Pandemic Triggers the Onset of Face Mask Era
Respirator Mask Records Significant Growth
Designers Revamp Face Masks into a Fashion Accessory
Surgical Drapes and Gowns: Indispensable for Safe Healthcare
Surgical Gowns Market: Stable Growth Outlook
High Demand for Disposable Drapes and Gowns
COVID-19 Outbreak Resulted in Massive Spike in Disposable Gloves Market
Growth in Medical Device Reprocessing to Offer New Areas of Growth
UV Disinfection Soaks up Limelight with COVID-19-Induced Disinfection Focus
Improving Healthcare Expenditure to Bode Well for Market Growth
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Technological Advancements
India Focuses on Development of COVID-19 Relevant Technologies for Disinfection and Sterilization
Sealive’s Biovector Sterilization Technology for more Effective Inactivation of Viruses and Microorganisms
Introduction of Business-Friendly Policies and Guidelines Fuel Demand for Eco-Friendly Medical Sterilization Equipment
Challenges and Future Prospects
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Protective Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Protective Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Protective Barriers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Sterilization Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Sterilization Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Sterilization Products & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Cleaning & Disinfection Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Cleaning & Disinfection Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Cleaning & Disinfection Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Endoscope Reprocessing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Endoscope Reprocessing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Endoscope Reprocessing Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Other Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Other Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Other Products & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Pharma & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 28: USA Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 29: USA Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: USA 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 31: USA Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: USA Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: USA 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
TABLE 34: Canada Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: Canada Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: Canada 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 37: Canada Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: Canada Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: Canada 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 40: Japan Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: Japan Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: Japan 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 43: Japan Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: Japan Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: Japan 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 46: China Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: China Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: China 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 49: China Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: China Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: China 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 52: Europe Recent Past, Current & Future Analysis for Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 53: Europe Historic Review for Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: Europe 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 55: Europe Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: Europe Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: Europe 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 58: Europe Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: Europe Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: Europe 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 61: France Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: France Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: France 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 64: France Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: France Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: France 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 67: Germany Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Germany Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Germany 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 70: Germany Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Germany Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: Germany 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
TABLE 73: Italy Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: Italy Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: Italy 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 76: Italy Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: Italy Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: Italy 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 79: UK Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: UK Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: UK 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 82: UK Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: UK Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: UK 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
SPAIN
TABLE 85: Spain Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Spain Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Spain 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 88: Spain Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Spain Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Spain 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
RUSSIA
TABLE 91: Russia Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Russia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: Russia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 94: Russia Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Russia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: Russia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 97: Rest of Europe Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Rest of Europe Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Rest of Europe 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 100: Rest of Europe Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 101: Rest of Europe Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 102: Rest of Europe 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 103: Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 104: Asia-Pacific Historic Review for Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 105: Asia-Pacific 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
TABLE 106: Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: Asia-Pacific Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 108: Asia-Pacific 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 109: Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 110: Asia-Pacific Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 111: Asia-Pacific 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
AUSTRALIA
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
TABLE 112: Australia Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: Australia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 114: Australia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 115: Australia Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 116: Australia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 117: Australia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
INDIA
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
TABLE 118: India Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: India Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 120: India 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 121: India Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 122: India Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 123: India 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
SOUTH KOREA
TABLE 124: South Korea Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 125: South Korea Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 126: South Korea 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 127: South Korea Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 128: South Korea Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 129: South Korea 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
TABLE 130: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 131: Rest of Asia-Pacific Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 132: Rest of Asia-Pacific 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 133: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 134: Rest of Asia-Pacific Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 135: Rest of Asia-Pacific 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
LATIN AMERICA
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 136: Latin America Recent Past, Current & Future Analysis for Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 137: Latin America Historic Review for Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 138: Latin America 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
TABLE 139: Latin America Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 140: Latin America Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 141: Latin America 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 142: Latin America Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 143: Latin America Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 144: Latin America 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
ARGENTINA
TABLE 145: Argentina Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 146: Argentina Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 147: Argentina 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 148: Argentina Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 149: Argentina Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 150: Argentina 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
BRAZIL
TABLE 151: Brazil Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 152: Brazil Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 153: Brazil 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 154: Brazil Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 155: Brazil Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 156: Brazil 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
MEXICO
TABLE 157: Mexico Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 158: Mexico Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 159: Mexico 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 160: Mexico Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 161: Mexico Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 162: Mexico 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
TABLE 163: Rest of Latin America Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 164: Rest of Latin America Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 165: Rest of Latin America 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 166: Rest of Latin America Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 167: Rest of Latin America Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 168: Rest of Latin America 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
MIDDLE EAST
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
TABLE 169: Middle East Recent Past, Current & Future Analysis for Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 170: Middle East Historic Review for Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 171: Middle East 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
TABLE 172: Middle East Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 173: Middle East Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 174: Middle East 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 175: Middle East Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 176: Middle East Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 177: Middle East 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
IRAN
TABLE 178: Iran Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 179: Iran Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 180: Iran 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 181: Iran Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 182: Iran Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 183: Iran 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
ISRAEL
TABLE 184: Israel Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 185: Israel Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 186: Israel 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 187: Israel Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 188: Israel Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 189: Israel 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
SAUDI ARABIA
TABLE 190: Saudi Arabia Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 191: Saudi Arabia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 192: Saudi Arabia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 193: Saudi Arabia Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 194: Saudi Arabia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 195: Saudi Arabia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
TABLE 196: UAE Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 197: UAE Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 198: UAE 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 199: UAE Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 200: UAE Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 201: UAE 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
TABLE 202: Rest of Middle East Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 203: Rest of Middle East Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 204: Rest of Middle East 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 205: Rest of Middle East Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 206: Rest of Middle East Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 207: Rest of Middle East 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
AFRICA
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
TABLE 208: Africa Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 209: Africa Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 210: Africa 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
TABLE 211: Africa Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 212: Africa Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 213: Africa 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 145

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings